Skip to main content
Equibles

AMRUTANJAN · Amrutanjan Health Care Limited · Financials

Use AMRUTANJAN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMRUTANJAN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
509.00 INR +1.50 (+0.30%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 2285 Avg daily vol (3M) 22.48K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
5.03B +11.2%
FY2026 Revenue FY2019–FY2026
Net Income
579.18M +13.9%
FY2026 Net Income FY2019–FY2026
Operating Cash Flow
359.68M -29.3%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
INR 5.29B 5.03B 4.52B 4.21B 3.8B 4.06B 3.33B 2.61B 2.53B
INR 86.36M 63.19M 65.26M 60.57M 52.12M 37.95M 36.7M 43.59M 31.6M
INR 1.82M 1.95M 2.19M 1.57M 771K 4.85M 5M 2.21M 822K
INR 765.46M 778.88M 691.34M 619.46M 536.45M 905.77M 819.05M 344.54M 351.67M
INR 192.55M 199.7M 182.99M 169.73M 138.11M 233.88M 207.14M 93.71M 101.7M
INR 572.91M 579.18M 508.35M 449.73M 398.35M 671.89M 611.9M 250.83M 245.14M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 667.43M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.